Aldosterone inhibits insulin-induced glucose uptake by degradation of insulin receptor substrate (IRS) 1 and IRS2 via a reactive oxygen species-mediated pathway in 3T3-L1 adipocytes.
about
Optimization of cardiac metabolism in heart failureModulation of glucose metabolism by the renin-angiotensin-aldosterone systemThe aldosterone-mineralocorticoid receptor pathway exerts anti-inflammatory effects in endotoxin-induced uveitisProgesterone inhibits glucose uptake by affecting diverse steps of insulin signaling in 3T3-L1 adipocytes.Aldosterone production and insulin resistance in healthy adultsIncreased aldosterone among HIV-infected women with visceral fat accumulationMineralocorticoid receptor antagonists and the metabolic syndromeThe involvement of aldosterone on vascular insulin resistance: implications in obesity and type 2 diabetes.Effects of aldosterone on insulin sensitivity and secretion.Aldosterone: a forgotten mediator of the relationship between psychological stress and heart diseaseRAAS Activation Is Associated With Visceral Adiposity and Insulin Resistance Among HIV-infected PatientsSpironolactone prevents chlorthalidone-induced sympathetic activation and insulin resistance in hypertensive patients.Effect of Selective Mineralocorticoid Receptor Blockade on Flow-Mediated Dilation and Insulin Resistance in Older Adults with Metabolic Syndrome.The renin angiotensin aldosterone system and insulin resistance in humans.Differential predictors of insulin resistance in nondiabetic salt-resistant and salt-sensitive subjects.Molecular and metabolic mechanisms of cardiac dysfunction in diabetes.Aldosterone in vascular and metabolic dysfunction.Effect of mineralocorticoid receptor antagonist on insulin resistance and endothelial function in obese subjects.The role of aldosterone in the metabolic syndrome.Mechanisms linking obesity to hypertension.The renin-angiotensin-aldosterone system and glucose homeostasis.Link between the renin-angiotensin system and insulin resistance: implications for cardiovascular disease.The impacts of obesity on the cardiovascular and renal systems: cascade of events and therapeutic approaches.The necessity and effectiveness of mineralocorticoid receptor antagonist in the treatment of diabetic nephropathy.Development of novel cell lines of diabetic dysfunction model fit for cell-based screening tests of medicinal materials.High glucose stimulates expression of aldosterone synthase (CYP11B2) and secretion of aldosterone in human adrenal cells.ISN Forefronts Symposium 2015: Nuclear Receptors and Diabetic NephropathyInsulin signaling in adipose tissue of patients with primary aldosteronism.Both type I and II IFN induce insulin resistance by inducing different isoforms of SOCS expression in 3T3-L1 adipocytes.Acute sodium ingestion has no effect on short-term food and water intake, subjective appetite, thirst, or glycemic response in healthy young men.Impact of Adrenal Steroids on Regulation of Adipose Tissue.Excess aldosterone-induced changes in insulin signaling molecules and glucose oxidation in gastrocnemius muscle of adult male rat.Eplerenone ameliorates the phenotypes of metabolic syndrome with NASH in liver-specific SREBP-1c Tg mice fed high-fat and high-fructose diet.
P2860
Q27023021-8E5064D3-0163-47BC-96AE-8A1F60FF5A06Q27026157-DACC6A62-3359-43B0-91B7-7319A415BB66Q28578431-408850A4-3419-4191-8042-D2D0C5E8CDE5Q33523666-5FF399B8-A2E2-41F4-A412-C74044238F27Q33786853-39F34CBA-4FA3-4A7A-A098-96A59DCB7418Q34066641-293EBBE3-B58B-446D-AAB0-5F4C4945232DQ34168923-50FFA668-06F2-4568-941D-2EED947659A9Q34409899-8D7B2EE7-831F-46AA-932C-F20A0BF11119Q34614820-B4A5207E-383B-4885-A076-B6CC189D9654Q34997222-58DAFFF6-5DD2-4D95-A2CC-D9423E539C9FQ35916560-01159424-FB32-469F-8AEB-51AC89D0A9CAQ36106582-07C4699C-4482-4B8D-B61C-60B41B62D61DQ36162444-F8262704-40F7-4A06-AD91-81833B8A5369Q36550987-E7D3410F-9CCC-440B-B6CA-6BCF8823B248Q36665733-71700B1F-6BFD-48BD-BE69-75BB4207D3EDQ36674142-4A20DC59-CBDD-4CCA-A8A4-133D446A0CEAQ36776435-DAE134B5-F345-471E-BFBC-AC2B59D1F7E3Q37624307-1EA714A2-8D33-41F3-974B-8D3DC83E674EQ37833554-3AA748D2-D3D6-462E-98DE-C0B60BEEAD90Q37914949-83551DDD-4A45-444F-B4A8-5CEE1B286CC3Q37924374-5DF6E923-5A75-4511-9AFD-398344777AC6Q38027785-89CB50B1-F234-470C-900A-31F6F295F753Q38332289-57F18BA0-7429-4E25-A7D3-76660120162DQ38374536-63676D49-A5B9-486A-94AF-95924D52BC37Q39317397-99362CC3-7B9B-4B26-A794-1D226D2941BFQ41627673-79CD8600-CD9F-4960-A53A-3C547CE6A67AQ41726958-25CB270D-4E7F-4D51-9B55-391FBA45EB9AQ42486942-959A742F-FBF1-407B-A264-22210529A5C0Q42813590-5B11F76E-270C-4E25-98CD-2F48FD56C3CAQ44821119-8AD4A33D-AEFD-41C9-9892-850E20AE4C5EQ50068164-002F4FDF-6F23-4680-AD18-B5194F2E7E04Q53143530-821FDAB0-C999-4236-A775-6FF5AF8D388CQ54753378-91F5FC2C-B256-467D-BE35-0C3E4B299552
P2860
Aldosterone inhibits insulin-induced glucose uptake by degradation of insulin receptor substrate (IRS) 1 and IRS2 via a reactive oxygen species-mediated pathway in 3T3-L1 adipocytes.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Aldosterone inhibits insulin-i ...... pathway in 3T3-L1 adipocytes.
@en
Aldosterone inhibits insulin-i ...... of insulin receptor substrate
@nl
type
label
Aldosterone inhibits insulin-i ...... pathway in 3T3-L1 adipocytes.
@en
Aldosterone inhibits insulin-i ...... of insulin receptor substrate
@nl
prefLabel
Aldosterone inhibits insulin-i ...... pathway in 3T3-L1 adipocytes.
@en
Aldosterone inhibits insulin-i ...... of insulin receptor substrate
@nl
P2093
P356
P1433
P1476
Aldosterone inhibits insulin-i ...... pathway in 3T3-L1 adipocytes.
@en
P2093
Daisuke Koya
Eriko Fujisawa
Hiroshi Tsuneki
Satoshi Ohshima
Toshiyasu Sasaoka
Tsutomu Wada
P304
P356
10.1210/EN.2008-1018
P407
P577
2008-12-18T00:00:00Z